Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors (RAPIRI)

This study is not yet open for participant recruitment.
Verified January 2011 by University Hospital, Strasbourg, France
Sponsor:
Collaborator:
Gustave Roussy, Cancer Campus, Grand Paris
Information provided by:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT01282697
First received: November 12, 2010
Last updated: January 24, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: August 2014
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)